Biogen · 4 months ago
Senior Manager, Global Pricing and Access
Cambridge, MA
Full-time
Onsite
Senior Level
$145K/yr - $194K/yr
5+ years expBiogen is a mid-sized biotechnology company dedicated to delivering life-changing medicines. They are seeking a Senior Manager for Global Pricing and Access to contribute insights on pricing and access strategies for their immunology pipeline, collaborating with various teams to inform product development and market access estimates.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Support Global Pricing and Access team members with value, pricing and access assessments of new immunology disease areas
Conduct secondary research determining price levels of existing therapies and payer management, HTA review outcomes for relevant products, and burden of disease to inform price and market access estimates, inform target product profile and clinical trials development program
Lead third party payer and analog research, integrating product’s value proposition and supporting clinical information, to determine achievable price, including gross to net, and market access for specific (or, across) indication(s), and optimal evidence package and indication sequencing
Develop pricing, market access, and gross-to-net assumptions for the forecast and financial model quantifying the business opportunity as part of the business development commercial evaluation
Align with the commercial partners on the overall commercial assumptions supporting the business case forecast
Represent the Global Value & Access team at the cross-functional meetings, and, when needed, at the various organizational governing bodies, to support the price and market access estimates input into the broader commercial evaluation
Support executive commercial management, when required, by briefing them on the price and access recommendation and supporting rationale in preparation for the review of business case by the broader Executive team
Qualification
Required
Master's degree in a related Business discipline including Business Administration, Finance, Economics, or Public Health, plus five (5) years of relevant Pricing and Reimbursement industry experience
Experience must include 3 years for the majority of the following:
Demonstrated understanding of payer environment, both US and globally, including coverage and reimbursement, value drivers, formulary management, health technologies assessment, and health policy
Experience in developing Global payer policy and strategies
Demonstrated understanding of pharmaceutical product development or commercialization
Demonstrated ability to develop deep therapeutic expertise
Experience supporting Business and Development assessments
Strong communication and influencing skills
Ability to work under pressure within short timeframes
Benefits
Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Founded in 1978Cambridge, Massachusetts, USA
5001-10000 employees
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Robin C. Kramer
Executive Vice President, Chief Financial Officer
Priya Singhal
Executive Vice President, Head of Development
Recent News
2026-01-16
2026-01-16
Company data provided by crunchbase